Endocrine Cancer

ENDOCRINE CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Risk of Cancer-Specific Death May Remain Elevated for 30 Years

Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
PTSD in Cancer Patients: What Providers Need to Know

Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
Genomic Sequencing in Pediatric Cancer: For Every Patient at Every Relapse

More than one-third of tumors sequenced carried a high mutation burden.
How to Prevent a Cyberattack from Derailing Cancer Care

Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
Platinum Chemotherapy Appears to Cause Clonal Expansion Leading to Myeloid Neoplasms in Children With Neuroblastoma

Children treated for neuroblastoma developed myeloid neoplasms with specific platinum chemotherapy-associated mutation signatures.

ENDOCRINE CANCER NEWS

Researchers have identified actionable alterations in nearly 38% of patients with cancer, and almost 18% of patients were assigned to treatments based on their molecular profiling results.

Molecular Profiling Can Guide Treatment After Recurrence in Young Cancer Patients

May 11, 2022

SARS-CoV-2

Risk of Breakthrough COVID-19 Varies by Cancer Type

April 12, 2022

Nurse writing in chart beside patient in hospital bed.

Pandemic Tied to Drop in New Cancer Diagnoses

March 29, 2022

Older female patient talking to doctor.

Radioiodine Provides No Benefit After Thyroidectomy in Low-Risk Thyroid Cancer

March 16, 2022

IV drip

Peptide Receptor Radionuclide Therapy Prolongs PFS in Enteropancreatic Neuroendocrine Tumors

March 9, 2022

Next post in Endocrine Cancer

Peptide Receptor Radionuclide Therapy Prolongs PFS in Enteropancreatic Neuroendocrine Tumors